Although it is possible that immunodeficiency in the mice might have affected the allograft study, results observed in PKF mice treated with anti-VCAM-1 antibody suggested that immunocompetent mice have similar responses in terms of sVCAM-1 mediated resistance to gemcitabine. The gene discussed is VCAM1; the disease is immune system disorder.